Smith Asset Management Group »

Ironwood Pharmaceuticals shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Ironwood Pharmaceuticals (IRWD) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Ironwood Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ironwood Pharmaceuticals held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ironwood Pharmaceuticals by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2011-03-31 $1.0B 72k 13980.00

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Ironwood Pharmaceuticals

BlackRock
Vanguard Group
Sarissa Capital Management
UBS Group
Pacer Advisors
State Street Corporation
Renaissance Technologies
Armistice Capital
LSV Asset Management
Braidwell
Jacobs Levy Equity Management
Kynam Capital Management
Geode Capital Management
Charles Schwab Investment Management
Northern Trust

View all funds holding Ironwood Pharmaceuticals